Supporting Patients via Twitter and Beyond
Although nearly two-thirds of respondents to a 2009/2010 Pharma Marketing News survey thought that using Twitter for patient support activities would be somewhat or very effective, relatively few pharmaceutical companies are doing this on a regular basis. From time to time, however, it does happen. Boehringer Ingelheim Shows How It's Done
Here Come the Pharma Wikipedians
The Pros and Cons of Pharma Employees Editing Wikipedia Articles. Should pharmaceutical companies appoint employees as Wikipedia 'spokespeople' to perform all edits to Wikipedia articles on behalf of the company?
Pharma Marketing News Vol. 11, No. 6: 29 June 2012
Welcome to Volume 11, Issue #6 (29 JUNE 2012) of Pharma Marketing News.
Drug Ads & Coupons: Who’s the Decider? The Patient, the Physician, or the FDA?
The FDA is concerned that the use of sales promotions such as free trial offers, discounts, money-back guarantees, and rebates in direct-to-consumer (DTC) prescription...
Bogus Predictions of Pharma Industry Online Ad Spending
Here's a headline, versions of which I have been seeing for years: "Pharmaceutical Advertising Spending Shifts to Digital." That's how Business 2 Community --...
Boehringer Ingelheim Shows How to Support Patients via Twitter and Beyond
One of the uses for pharma Twitter accounts that many ePatient advocates recommend is to directly support patients seeking help regarding their Rx products...
FDA Concerned About Product (eg, Lyrica) Ads That are Too “Educational”
In a recent Federal Register notice (find it here), FDA outlined a study it plans to do to determine if disease awareness information in...
Here Come the Pharma Wikipedians!
Should pharmaceutical companies appoint employees as Wikipedia "spokespeople" to perform all edits to Wikipedia articles on behalf of the company? That is the opinion...
Abbott’s Anti-Biosimilar Stance is Anti-Consumer
The pharmaceutical industry often wonders why it has such a bad reputation with consumers -- nearly as bad as the tobacco industry -- considering...
“Low Hanging Fruit” Keeps FDA Busy & Out of Pharma’s Social Media Hair
Another tidbit I picked up this week at CBI's 3rd Annual Forum on Social Media Regulations and Compliance is the notion that the FDA...
